Literature DB >> 1325367

Cytosolic and membrane-bound cyclic nucleotide phosphodiesterases from guinea pig cardiac ventricles.

B Muller1, J C Stoclet, C Lugnier.   

Abstract

Cyclic nucleotide phosphodiesterase (PDE) activities were characterized in the cytosolic and post-nuclear membrane preparations of guinea pig cardiac ventricles. The cytosolic PDE activities were stimulated 5-fold by calmodulin (CaM) on both substrates (1 microM) and 1.2-fold by cGMP (5 microM) on cAMP hydrolysis. Conversely, in the membrane preparation, CaM only stimulated PDE activities 1.2- to 1.4-fold, but cGMP induced a 3-fold increase of the hydrolysis of cAMP. In both the cytosolic and the membrane preparations, the hydrolysis of cAMP was inhibited by 100 microM of either the PDE III inhibitor SK&F 94120 (27% and 31% respectively) or the PDE IV inhibitor rolipram (14% and 23% respectively). Four peaks were resolved from the cytosolic preparation by chromatography. Peak A and peak B hydrolyzed both cAMP and cGMP and were stimulated respectively by CaM and cGMP. Peak C and peak D selectively hydrolyzed cAMP. Peak C had an apparent Km value for cAMP of 3.3 microM and was inhibited by PDE IV inhibitors. Peak D showed an apparent Km value for cAMP of 0.43 microM and was inhibited by cGMP and by cardiotonic inhibitors of PDE III. Similar potencies of these inhibitors were observed in the membrane preparation. These results suggest that in guinea pig cardiac ventricles: (1) PDE I (CaM-activated) is almost exclusively cytosolic; (2) PDE II (cGMP-stimulated), PDE III (cGMP-inhibited and cardiotonic-sensitive) and PDE IV (rolipram-sensitive) are present in cytosolic and membrane preparations; (3) PDE III and PDE IV differ in their apparent Km values for cAMP. The latter observation could explain the differential effects of PDE III and PDE IV inhibitors in the regulation of cardiac contraction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325367     DOI: 10.1016/0922-4106(92)90028-t

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Species differences in localization of cardiac cAMP-phosphodiesterase activity: a cytochemical study.

Authors:  L Okruhlicová; N Tribulová; J Styk; A Eckly; C Lugnier; J Slezk
Journal:  Mol Cell Biochem       Date:  1997-08       Impact factor: 3.396

2.  Local response of L-type Ca(2+) current to nitric oxide in frog ventricular myocytes.

Authors:  M Dittrich; J Jurevicius; M Georget; F Rochais; B Fleischmann; J Hescheler; R Fischmeister
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

3.  Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.

Authors:  E Delpy; H Coste; A C Gouville
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

Review 4.  Compartmentalized cAMP signaling in cardiac ventricular myocytes.

Authors:  Shailesh R Agarwal; Rinzhin T Sherpa; Karni S Moshal; Robert D Harvey
Journal:  Cell Signal       Date:  2021-10-20       Impact factor: 4.315

Review 5.  Mechanisms of cAMP compartmentation in cardiac myocytes: experimental and computational approaches to understanding.

Authors:  Robert D Harvey; Colleen E Clancy
Journal:  J Physiol       Date:  2021-09-27       Impact factor: 6.228

6.  Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes.

Authors:  Liliana R V Castro; Ignacio Verde; Dermot M F Cooper; Rodolphe Fischmeister
Journal:  Circulation       Date:  2006-05-01       Impact factor: 29.690

7.  Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.

Authors:  A E Eckly; C Lugnier
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

8.  Long lasting anti-adrenergic effect of 7-oxo-prostacyclin in the heart: a cycloheximide sensitive increase of phosphodiesterase isoform I and IV activities.

Authors:  G Borchert; S Bartel; I Beyerdörfer; I Küttner; L Szekeres; E G Krause
Journal:  Mol Cell Biochem       Date:  1994-03-16       Impact factor: 3.396

9.  Cytochemical distribution of cyclic AMP-dependent 3',5'-nucleotide phosphodiesterase in the rat myocardium.

Authors:  L Okruhlicová; N Tribulová; A Eckly; C Lugnier; J Slezák
Journal:  Histochem J       Date:  1996-03

10.  Effects of saterinone and its enantiomers R(+)-saterinone and S(-)-saterinone on the phosphodiesterase isoenzymes from ventricular tissue of failing human hearts and porcine hearts.

Authors:  W Zimmermann; H Scholz; C Schumacher; H Wenzlaff; A Haverich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.